Literature DB >> 8945529

Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunity.

S Baqar1, A L Bourgeois, L A Applebee, A S Mourad, M T Kleinosky, Z Mohran, J R Murphy.   

Abstract

Campylobacter jejuni infection of mice initiated by intranasal administration was investigated as a potential model for studies of pathogenesis and immunity. By using a standard challenge (5 x 10(9) CFU), C. jejuni 81-176 was more virulent for BALB/c (72% mortality) than for C3H/Hej (50%), CBA/CAJ (30%), or C58/J (0%). Intranasal challenge of BALB/c was used to compare the relative virulence of three reference strains; C.jejuni 81-176 was more virulent (killing 83% of challenged mice) than C. jejuni HC (0%) or C. coli VC-167 (0%). The course of intranasally initiated C. jejuni 81-176 infection in BALB/c was determined. C. jejuni was recovered from the lungs, intestinal tract, liver, and spleen at 4 h after challenge, the first interval evaluated. After this initial interval, three distinct patterns of infection were recognized: (i) a progressive decline in number of C. jejuni CFU (stomach, blood, lungs), (ii) decline followed by a second peak in the number of organisms recovered at 2 or 3 days postchallenge (intestine, liver, mesenteric lymph nodes), and (iii) persistence of approximately the same number of C.jejuni CFU during the course of the experiment (spleen). Intranasally induced infection initiated with a sublethal number of bacteria or intranasal immunization with killed Campylobacter preparations resulted in both the generation of Campylobacter antigen-specific immune responses and an acquired resistance to homologous rechallenge. The model was used to evaluate the relative virulence of nine low-in vitro-passage (no more than five passages) isolates of C. jejuni species from patients with diarrhea. The patient isolates were differentially virulent for mice; one killed all exposed mice, three were avirulent (no deaths) and the remainder showed an intermediate virulence, killing 17 to 33%. Mouse virulence of Campylobacter strains showed a trend toward isolates originating from individuals with watery diarrhea; however, no association was found between mouse virulence and other signs or symptoms. There were no observed relationships between mouse virulence and bacterial Lior serotype or Fla polymorphic group. Intranasal challenge of BALB/c with C. jejuni is a useful model for the study of infection and vaccination-acquired immunity to this agent.

Entities:  

Mesh:

Year:  1996        PMID: 8945529      PMCID: PMC174471          DOI: 10.1128/iai.64.12.4933-4939.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Host defense against cholera toxin is strongly CD4+ T cell dependent.

Authors:  E Hörnqvist; T J Goldschmidt; R Holmdahl; N Lycke
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

2.  A domestic ferret model of immunity to Campylobacter jejuni-induced enteric disease.

Authors:  J A Bell; D D Manning
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

3.  Experimental Campylobacter jejuni infection in humans.

Authors:  R E Black; M M Levine; M L Clements; T P Hughes; M J Blaser
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

4.  Infection of adult Syrian hamsters with flagellar variants of Campylobacter jejuni.

Authors:  M E Aguero-Rosenfeld; X H Yang; I Nachamkin
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

5.  Distribution and polymorphism of the flagellin genes from isolates of Campylobacter coli and Campylobacter jejuni.

Authors:  R A Alm; P Guerry; T J Trust
Journal:  J Bacteriol       Date:  1993-05       Impact factor: 3.490

6.  Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model.

Authors:  C P Mallett; L VanDeVerg; H H Collins; T L Hale
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

7.  The mechanism of protection of infant mice from intestinal colonisation with Campylobacter jejuni.

Authors:  A G Abimiku; J M Dolby
Journal:  J Med Microbiol       Date:  1987-06       Impact factor: 2.472

8.  Campylobacter diarrhea in an adult mouse model.

Authors:  J T Stanfield; B A McCardell; J M Madden
Journal:  Microb Pathog       Date:  1987-09       Impact factor: 3.738

9.  Campylobacter jejuni infection in the ferret: an animal model of human campylobacteriosis.

Authors:  J G Fox; J I Ackerman; N Taylor; M Claps; J C Murphy
Journal:  Am J Vet Res       Date:  1987-01       Impact factor: 1.156

10.  Early colonic damage and invasion of Campylobacter jejuni in experimentally challenged infant Macaca mulatta.

Authors:  R G Russell; M O'Donnoghue; D C Blake; J Zulty; L J DeTolla
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

View more
  22 in total

1.  New World monkey Aotus nancymae as a model for Campylobacter jejuni infection and immunity.

Authors:  Franca R Jones; Shahida Baqar; Alfonso Gozalo; Gladys Nunez; Nereyda Espinoza; Sharina M Reyes; Milagros Salazar; Rina Meza; Chad K Porter; Stephen E Walz
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Campylobacter jejuni-stimulated secretion of interleukin-8 by INT407 cells.

Authors:  T E Hickey; S Baqar; A L Bourgeois; C P Ewing; P Guerry
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice.

Authors:  Z Pei; C Burucoa; B Grignon; S Baqar; X Z Huang; D J Kopecko; A L Bourgeois; J L Fauchere; M J Blaser
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni.

Authors:  L H Lee; E Burg; S Baqar; A L Bourgeois; D H Burr; C P Ewing; T J Trust; P Guerry
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  The Human Milk Oligosaccharide 2'-Fucosyllactose Quenches Campylobacter jejuni-Induced Inflammation in Human Epithelial Cells HEp-2 and HT-29 and in Mouse Intestinal Mucosa.

Authors:  Zhuo-Teng Yu; N Nanda Nanthakumar; David S Newburg
Journal:  J Nutr       Date:  2016-09-14       Impact factor: 4.798

6.  Immunogenicity and immunoprotection of recombinant PEB1 in Campylobacter-jejuni-infected mice.

Authors:  Lian-Feng Du; Zhen-Jiang Li; Xian-Ying Tang; Jun-Qiong Huang; Wan-Bang Sun
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

7.  Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection.

Authors:  Nadia Al-Banna; Raj Raghupathy; M John Albert
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

8.  Intranasal immunization with chitosan/pCAGGS-flaA nanoparticles inhibits Campylobacter jejuni in a White Leghorn model.

Authors:  Jin-lin Huang; Yan-Xin Yin; Zhi-ming Pan; Gong Zhang; Ai-ping Zhu; Xiu-fan Liu; Xin-an Jiao
Journal:  J Biomed Biotechnol       Date:  2010-08-16

9.  Immune response to and histopathology of Campylobacter jejuni infection in ferrets (Mustela putorius furo).

Authors:  Kevin W Nemelka; Ammon W Brown; Shannon M Wallace; Erika Jones; Ludmila V Asher; Dawn Pattarini; Lisa Applebee; Theron C Gilliland; Patricia Guerry; Shahida Baqar
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

Review 10.  Host-pathogen interactions in Campylobacter infections: the host perspective.

Authors:  Riny Janssen; Karen A Krogfelt; Shaun A Cawthraw; Wilfrid van Pelt; Jaap A Wagenaar; Robert J Owen
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.